Literature DB >> 30167727

[Pediatric urological challenges in refugee children].

A Hofmann1,2, W H Rösch3.   

Abstract

In recent years, the number of refugees to Germany has risen dramatically. Nearly half of the refugees are under 18, and a large percentage of them have acute or chronic medical problems. This situation poses a unique challenge to pediatric hospitals. Interprofessional teams in pediatric urology departments must care for an increasing number of patients with genetic abnormalities and diseases, unusual urogenital trauma, as well as frequent multiresistent organisms. In addition, communication problems due to language barriers and intercultural differences abound. Successful urological care for these patients requires not only high technical skills, dedication and empathy, but also the ability to reflect on and adapt to different cultural perspectives.

Entities:  

Keywords:  Female genital mutilation; Genetic diseases, inborn; Intercultural competence; Multi-drug-resistance; Urogenital traumas

Mesh:

Year:  2018        PMID: 30167727     DOI: 10.1007/s00120-018-0761-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  12 in total

1.  Multidrug-resistant organisms detected in refugee patients admitted to a University Hospital, Germany June‒December 2015.

Authors:  Claudia Reinheimer; Volkhard A J Kempf; Stephan Göttig; Michael Hogardt; Thomas A Wichelhaus; Fiona O'Rourke; Christian Brandt
Journal:  Euro Surveill       Date:  2016

2.  [Hygiene measures for infection or colonization with multidrug-resistant gram-negative bacilli. Commission recommendation for hospital hygiene and infection prevention (KRINKO) at the Robert Koch Institute (RKI)].

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2012-10       Impact factor: 1.513

3.  The sale of antibiotics without prescription in pharmacies in Damascus, Syria.

Authors:  Zaid Al-Faham; Ghaith Habboub; Farah Takriti
Journal:  J Infect Dev Ctries       Date:  2011-05-28       Impact factor: 0.968

4.  Resistance trends and risk factors of extended spectrum β-lactamases in Escherichia coli infections in Aleppo, Syria.

Authors:  Bodour Al-Assil; Maysa Mahfoud; Abdul Rezzak Hamzeh
Journal:  Am J Infect Control       Date:  2013-01-20       Impact factor: 2.918

Review 5.  [Increase in genetically determined anemia as a result of migration in Germany].

Authors:  B Zur
Journal:  Internist (Berl)       Date:  2016-05       Impact factor: 0.743

6.  Lower genitourinary trauma in modern warfare: the experience from civil violence in Iraq.

Authors:  Issam S Al-Azzawi; Mamdouh M Koraitim
Journal:  Injury       Date:  2014-01-14       Impact factor: 2.586

7.  Prevalence of Multidrug-Resistant Organisms in Hospitalized Pediatric Refugees in an University Children's Hospital in Germany 2015-2016.

Authors:  Tobias Tenenbaum; Klaus-Peter Becker; Bettina Lange; Anka Martin; Peter Schäfer; Stefan Weichert; Horst Schroten
Journal:  Infect Control Hosp Epidemiol       Date:  2016-08-15       Impact factor: 3.254

8.  Multidrug-Resistant Bacteria in Refugee Children and Pregnant Women Admitted to a General Hospital in North Rhine-Westphalia, Germany.

Authors:  C Krüger; S Schuler-Lüttmann; T Haug; M Gantert; M Hermsen
Journal:  Klin Padiatr       Date:  2016-06-30       Impact factor: 1.349

9.  A crisis of protection and safe passage: violence experienced by migrants/refugees travelling along the Western Balkan corridor to Northern Europe.

Authors:  Jovana Arsenijević; Erin Schillberg; Aurelie Ponthieu; Lucio Malvisi; Waeil A Elrahman Ahmed; Stefano Argenziano; Federica Zamatto; Simon Burroughs; Natalie Severy; Christophe Hebting; Brice de Vingne; Anthony D Harries; Rony Zachariah
Journal:  Confl Health       Date:  2017-04-16       Impact factor: 2.723

10.  Multidrug-Resistant Pathogens in Hospitalized Syrian Children.

Authors:  Diana Faour Kassem; Yoav Hoffmann; Naama Shahar; Smadar Ocampo; Liora Salomon; Zeev Zonis; Daniel Glikman
Journal:  Emerg Infect Dis       Date:  2017-01-15       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.